Bahjat A. Faraj

1.5k total citations
65 papers, 1.2k citations indexed

About

Bahjat A. Faraj is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Bahjat A. Faraj has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Biochemistry, 13 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in Bahjat A. Faraj's work include Metabolism and Genetic Disorders (15 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Alcohol Consumption and Health Effects (7 papers). Bahjat A. Faraj is often cited by papers focused on Metabolism and Genetic Disorders (15 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Alcohol Consumption and Health Effects (7 papers). Bahjat A. Faraj collaborates with scholars based in United States, United Kingdom and Lebanon. Bahjat A. Faraj's co-authors include Vernon M. Camp, Richard T. Jackson, Zbigniew L. Olkowski, Jerrold H. Levy, James R. Zaidan, J Chipponi, Peter G. Dayton, Zafar H. Israili, Michael Kutner and Daniel Rudman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Bahjat A. Faraj

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bahjat A. Faraj United States 19 267 223 219 162 144 65 1.2k
R Arendt Germany 21 380 1.4× 256 1.1× 278 1.3× 150 0.9× 92 0.6× 59 1.5k
H. Meinhold Germany 29 280 1.0× 519 2.3× 200 0.9× 132 0.8× 103 0.7× 101 2.6k
Maria Luisa Zeneroli Italy 21 341 1.3× 207 0.9× 232 1.1× 245 1.5× 370 2.6× 58 1.3k
D. Platt Germany 18 103 0.4× 228 1.0× 118 0.5× 81 0.5× 135 0.9× 91 1.2k
C. Cangiano Italy 28 131 0.5× 321 1.4× 114 0.5× 160 1.0× 310 2.2× 63 1.7k
F. J. Carmichael Canada 26 390 1.5× 355 1.6× 296 1.4× 44 0.3× 250 1.7× 60 1.7k
P.J. Salt United Kingdom 14 255 1.0× 335 1.5× 198 0.9× 49 0.3× 43 0.3× 24 1.1k
Robert P. Davis United States 24 409 1.5× 528 2.4× 822 3.8× 95 0.6× 150 1.0× 79 2.2k
Laura Bossi France 20 273 1.0× 231 1.0× 69 0.3× 341 2.1× 123 0.9× 55 1.3k
Garland A. Johnson United States 14 328 1.2× 456 2.0× 353 1.6× 63 0.4× 75 0.5× 20 2.4k

Countries citing papers authored by Bahjat A. Faraj

Since Specialization
Citations

This map shows the geographic impact of Bahjat A. Faraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bahjat A. Faraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bahjat A. Faraj more than expected).

Fields of papers citing papers by Bahjat A. Faraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bahjat A. Faraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bahjat A. Faraj. The network helps show where Bahjat A. Faraj may publish in the future.

Co-authorship network of co-authors of Bahjat A. Faraj

This figure shows the co-authorship network connecting the top 25 collaborators of Bahjat A. Faraj. A scholar is included among the top collaborators of Bahjat A. Faraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bahjat A. Faraj. Bahjat A. Faraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faraj, Bahjat A., et al.. (1994). The effect of cocaine abuse on plasma levels of sulfated dopamine and salsolinol in alcoholics. Alcohol. 11(4). 337–342. 2 indexed citations
2.
Faraj, Bahjat A., Zbigniew L. Olkowski, & Richard T. Jackson. (1994). Active [<sup>3</sup>H]-Dopamine Uptake by Human Lymphocytes: Correlates with Serotonin Transporter Activity. Pharmacology. 48(5). 320–327. 28 indexed citations
3.
Faraj, Bahjat A., et al.. (1994). Platelet Monoamine Oxidase Activity in Alcoholics, Alcoholics with Drug Dependence, and Cocaine Addicts. Alcoholism Clinical and Experimental Research. 18(5). 1114–1120. 26 indexed citations
4.
Faraj, Bahjat A., Vernon M. Camp, & Michael Kutner. (1991). Interrelationship between Activation of Dopaminergic Pathways and Cerebrospinal Fluid Concentration of Dopamine Tetrahydroisoquinoline Metabolite Salsolinol in Humans: Preliminary Findings. Alcoholism Clinical and Experimental Research. 15(1). 86–89. 9 indexed citations
5.
Schwieger, Ian M., et al.. (1990). Evaluation of Patients at Risk for Protamine Reactions. Survey of Anesthesiology. 34(3). 157–157. 2 indexed citations
6.
Pais, Ray, et al.. (1990). Abnormal vitamin B6 status in childhood leukemia. Cancer. 66(11). 2421–2428. 11 indexed citations
7.
Faraj, Bahjat A., V M Camp, & Ray L. Watts. (1990). Effect of adrenal-caudate transplantation on CSF levels of salsolinol sulfate in patients with Parkinson’s disease. PubMed. 32. 481–484. 5 indexed citations
8.
Faraj, Bahjat A., et al.. (1989). Elevation of Plasma Salsolinol Sulfate in Chronic Alcoholics as Compared to Nonalcoholics. Alcoholism Clinical and Experimental Research. 13(2). 155–163. 36 indexed citations
9.
Levy, Jerrold H., Bahjat A. Faraj, James R. Zaidan, & V M Camp. (1989). Effects of protamine on histamine release from human lung. Inflammation Research. 28(1-2). 70–72. 10 indexed citations
10.
Levy, Jerrold H., Ian M. Schwieger, James R. Zaidan, Bahjat A. Faraj, & William Weintraub. (1989). Evaluation of patients at risk for protamine reactions. Journal of Thoracic and Cardiovascular Surgery. 98(2). 200–204. 92 indexed citations
11.
Faraj, Bahjat A., et al.. (1988). Treatment of tyramine-induced brain edema with anion transport inhibitor L-644, 711. Life Sciences. 42(24). 2429–2437. 5 indexed citations
12.
Levy, Jerrold H., James R. Zaidan, & Bahjat A. Faraj. (1986). Prospective Evaluation of Risk of Protamine Reactions in Patients with NPH Insulin-Dependent Diabetes. Anesthesia & Analgesia. 65(7). 739???742–739???742. 74 indexed citations
13.
Faraj, Bahjat A., et al.. (1984). Hypercatecholaminemia in Reye's syndrome.. PubMed. 73(4). 481–8. 8 indexed citations
14.
Faraj, Bahjat A., et al.. (1984). Development of a sensitive radioassay of histamine for in vitro allergy testing.. PubMed. 25(1). 56–63. 19 indexed citations
15.
Faraj, Bahjat A., et al.. (1981). Development and application of a radioimmunoassay for tetracycline.. Journal of Pharmacology and Experimental Therapeutics. 217(1). 10–14. 16 indexed citations
16.
Rudman, Daniel, Steven D. Moffitt, Paul M. Fernhoff, R. Dwain Blackston, & Bahjat A. Faraj. (1981). Epinephrine Deficiency in Hypocorticotropic Hypopituitary Children*. The Journal of Clinical Endocrinology & Metabolism. 53(4). 722–729. 34 indexed citations
17.
Faraj, Bahjat A., et al.. (1979). Evidence for hypertyraminemia in Reye's syndrome.. PubMed. 64(1). 76–80. 13 indexed citations
18.
Nordlinger, Bernard, et al.. (1978). Deranged tyrosine metabolism in cirrhosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 51(6). 625–33. 13 indexed citations
19.
Faraj, Bahjat A., et al.. (1977). The measurement of 3-o-methyldopamine in urine and plasma by a rapid and specific radioimmunoassay.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(10). 1027–33. 7 indexed citations
20.
Faraj, Bahjat A., et al.. (1977). Studies of the fate of tyramine in dogs: the effect of monoamine oxidase inhibition, portafemoral shunt and coronary artery ligation on the kinetics of tyramine.. Journal of Pharmacology and Experimental Therapeutics. 200(2). 384–393. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026